Top Dialysis Companies

Dialysis Market size was valued at USD 120.82 Billion in 2024 and is poised to grow from USD 126.04 Billion in 2025 to USD 176.79 Billion by 2033, growing at a CAGR of 4.32% during the forecast period (2026–2033).

Making dialysis affordable and accessible to patients of all financial classes should be the prime focus of all market players in the future. Investing in the research and development of advanced dialysis technologies and launching new products are also expected to be preferred strategies. Collaborations and partnerships can help dialysis companies fast-track their product innovation and approval process in the long run. 'Asahi Kasei Corporation ', 'B. Braun Melsungen AG ', 'Baxter International Inc. ', 'Becton Dickinson and Company ', 'DaVita Inc. ', 'Fresenius Medical Care AG & Co. KGaA ', 'JMS Co. Ltd. ', 'Medtronic plc ', 'Nikkiso Co. Ltd. ', 'NIPRO Corporation ', 'Satellite Healthcare Inc. ', 'Toray Industries Inc. ', 'Diaverum Deutschland GmbH ', 'NxStage Medical, Inc. ', 'Rockwell Medical Technologies, Inc. ', 'AllMed Medical GmbH ', 'Fresenius Kabi AG ', 'Quanta Dialysis Technologies Ltd. ', 'Outset Medical, Inc. ', 'Medica S.p.A'

Factors such as poor nutrition, sedentary lifestyles, diabetes, and hypertension have resulted in a high prevalence of chronic kidney disease (CKD) around the world. Progression of CKD to end-stage renal disease (ESRD) leads to patients needing dialysis or complete kidney transplantation thereby favoring dialysis market growth as well.  

Demand for Home Dialysis: Dialysis providers are expected to focus on providing home dialysis services as the popularity of home healthcare increases globally. Increasing preference of patients to get treatment from the comfort of their homes is expected to promote the sales of easy-to-use home dialysis machines in the future.  

North America is projected to account for a dominant share of the global dialysis market. The rising number of people requiring dialysis, the presence of an increasing geriatric population, and high prevalence of chronic kidney disorders are prime factors allowing North America to spearhead the global dialysis industry landscape. Canada and the United States are estimated to be the leading markets for dialysis providers operating in North America. Growing preference and popularity of home healthcare is also expected to present new opportunities for dialysis companies in this region through 2031.  Availability of favorable reimbursement policies can also promote the demand for dialysis in North America.